Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Beyond Air Inc

XAIR ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: BUY

Last Close

$6.32

▼ -8.74%

Market Cap $6.05M · Vol 4.49K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$6.05M

Micro Cap

Div Yield

N/A

EPS Growth

+91.58%

YoY

RSI (14)

59.09

Momentum

Beta

0.22

vs Market

52W High

$95.60

93.39% below

52W Low

$5.10

23.82% above

Volume

4.49K

Avg 8.16K

P/B

1.33

Price-to-book

ROE

N/A

Return on equity

Free Float

87.55%

Public shares

Shariah Compliance8 STANDARDS

✗ Beyond Air Inc (XAIR) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does XAIR pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+17.82%

+9.45%

-32.82%

-69.93%

YTD

-56.51%

-86.39%

-99.52%

-99.80%

Financials & Valuation

TTM · Annual

Total Revenue	$7.68M
Net Income	$-34,334,000.00
Revenue Growth (YoY)	+65.54%
Gross Margin	3.28%
Operating Margin	-378.23%
Net Profit Margin	-447.12%
ROE	N/A
ROA · ROIC	-104.92% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.75
P/B	1.33
P/FCF	N/A
EPS Growth	+91.58%
Outstanding Shares	957.63K

Technical Indicators

50-Day SMA	$7.12
200-Day SMA	$16.44
RSI (14)	59.09
Beta	0.22
52-Week High	$95.60
52-Week Low	$5.10

Volume Today	4.49K
Avg Daily Volume (30D)	8.16K
Relative Volume	0.55x
Volatility (10D)	142.60
Volatility (30D)	122.83
Free Float	87.55%

Analyst Consensus

BUY

Current Price $6.32

Mean Target $30.00

52W Low$5.10 52W High$95.60

Current

Target

$5.10 $95.60

Current Analyst target

+375.06% upside potential · 2 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00B4QYL63

ISINUS08862L2025

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 10, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.